Moderna Inc (MRNA)

Currency in USD
55.14
+0.32(+0.58%)
Closed·
55.46+0.32(+0.58%)
·

MRNA Earnings

Latest Release
Jul 31, 2026
EPS / Forecast
-1.97 / -2.03
Revenue / Forecast
100M / 99.91M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2026--/-1.14--/902.98M----Free Sign Up
06/2026-1.97/-2.03100.00M/99.91M+2.96%+0.09%Free Sign Up
03/2026-3.40/-2.02389.00M/251.76M-68.32%+54.51%Free Sign Up
12/2025-2.11/-2.62678.00M/662.84M+19.47%+2.29%Free Sign Up
09/2025-0.510/-2.051.02B/909.97M+75.12%+12.09%Free Sign Up
06/2025-2.13/-2.98142.00M/114.40M+28.52%+24.13%Free Sign Up
03/2025-2.52/-3.18108.00M/115.30M+20.75%-6.33%Free Sign Up
12/2024-2.91/-2.73966.00M/995.44M-6.59%-2.96%Free Sign Up
09/20240.030/-1.921.86B/1.24B+101.56%+50%Free Sign Up
06/2024-3.33/-3.35241.00M/128.41M+0.6%+87.68%Free Sign Up

All numbers in USD

Moderna Inc Earnings Call Summary for Q2/2026

  • Moderna posted Q2 2026 adjusted loss of $1.97/share, beating estimates of $2.03, on revenue of $145M, up 2% YoY; shares rose 3.67% premarket.
  • Company narrowed net loss to $782M from $825M YoY through cost controls; R&D down 7%, SG&A down 6%, and cash costs reduced 10% versus Q2 2025.
  • Moderna lowered 2026 operating expense guidance by $200M to $4.7B and cut cash cost outlook by $200M to $4.0B while maintaining growth investments.
  • Management reaffirmed up to 10% revenue growth for 2026, expects stronger H2 with Q3 representing ~55% of second-half revenue; year-end cash projected at $4.7B-$5.2B.
  • Key catalysts include Aug. 5 FDA decision on flu vaccine mRNA-1010 and H2 2026 interim melanoma data; appointed Ester Banque as chief commercial officer.
Last Updated: 31/07/2026, 14:18
Read Full Transcript

FAQ

What Is Moderna's Earnings Per Share (TTM)?

The Moderna EPS (TTM) is -8.01.

When Is The Next Moderna Earnings Date?

Moderna will release its next earnings report on Oct 29, 2026.

What Is Moderna’s Revenue Forecasts For Upcoming Quarters?

Moderna’s revenue forecast is 902.98M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.